IRIS Sets a New Benchmark in Ocular Surface Disease Analysis
IRIS, a groundbreaking system in ocular surface disease (OSD) analysis, outshines larger models with its efficient use of structured data. This innovation could revolutionize mobile edge applications.
Read the full articleYou might also wanna read
New Collection: Multimodal AI in Retinal Disease: Imaging, Clinical Data, and Real‑World Endpoints
We are pleased to announce a new collection in International Ophthalmology, focusing on AI in ophthalmology.
WashU Medicine researchers develop AI system to interpret 3D retinal scans for faster disease diagnosis
Study finds that programs that analyze eye images could also speed up drug trials
<![CDATA[Advancing Ocular Oncology: Liquid Biopsies and Vision-Preserving Innovations]]>
AI Foundation Model Improves Ophthalmologist Diagnostic Accuracy in Randomized Controlled Trial
In the context of an increasing need for clinical assessments of foundation models, we developed EyeFM, a multimodal vision–language eyecare
Smartphone AI app detects eye surface cancers with near-specialist accuracy, study finds
A smartphone-based Artificial Intelligence application has been shown to detect cancers on the surface of the eye with near-specialist accur
Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
Conditions : Transthyretin Amyloid Cardiomyopathy Sponsors : AstraZeneca Not yet recruiting

Comments
Sign in to join the conversation.
No comments yet. Be the first.